Results 181 to 190 of about 55,263 (257)

Chemical inhibition of SUMOylation activates the FSHD locus. [PDF]

Sci Rep
Nordlinger A, Morin L, Andrieux A, Trani JP, Perrin P, Eudes N, Bigot A, Dejean A, Magdinier F.   +8 more
europepmc   +1 more source

Safety of Anesthesia With Dexmedetomidine for Muscle and Nerve Biopsy - A Review of 100 Cases. [PDF]

Cureus
Uruha S, Uruha A, Kawazoe T, Mukai M, Miyake N, Fukuda S, Matayoshi H, Sugaya K, Takahashi K.   +8 more
europepmc   +1 more source

Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double-blind placebo-controlled crossover trial. [PDF]

Pharmacotherapy
Woodcock IR, de Valle K, Cairns A, Davidson ZE, Kean M, Varma N, Grobler A, Metz D, Carroll K, Dilek N, Heatwole C, Ryan MM, Delatycki MB, Yiu EM.   +13 more
europepmc   +1 more source

Current landscape for the management of facioscapulohumeral muscular dystrophy and emerging treatment modalities: A literature review. [PDF]

AIMS Neurosci
Ansari U, Nadora D, Ong L, Sedighi R, Tabaie E, Ansari Z, Alam M, Syed B, Amani N, Preiss-Farzanegan S.   +9 more
europepmc   +1 more source

Novel biomarkers of changes in muscle mass or muscle pathology [PDF]

, 2017
Arvanitidis, Athanasios
core  

Increased <i>METTL3</i> Expression and m6A Methylation in Myoblasts of Facioscapulohumeral Muscular Dystrophy. [PDF]

Int J Mol Sci
Settas N, Bittel AJ, Chen YW.
europepmc   +1 more source

DUX4 at 25: how it emerged from "junk DNA" to become the cause of facioscapulohumeral muscular dystrophy. [PDF]

Skelet Muscle
Belayew A, Rosa AL, Zammit PS.
europepmc   +1 more source

Next-generation sequencing for pediatric-onset neuromuscular disorders unresolved by conventional diagnostic methods. [PDF]

Pediatr Res
Kulsirichawaroj P, Chanvanichtrakool M, Wattanadilokchatkun P, Pho-Iam T, Limwongse C, Likasitwattanakul S, Boonyapisit K, Sanmaneechai O, Nishino I, Shotelersuk V, Han J, Zuchner S.   +11 more
europepmc   +1 more source

Deep learning-based acceleration of muscle water T2 mapping in patients with neuromuscular diseases by more than 50% - translating quantitative MRI from research to clinical routine. [PDF]

PLoS One
Schmitt J, Weidlich D, Weiss K, Stelter J, Montagnese F, Deschauer M, Schoser B, Zimmer C, Karampinos DC, Kirschke JS, Schlaeger S.   +10 more
europepmc   +1 more source

Camptocormia as a Phenotypic Variant of FSHD in the Elderly: Clinical, Genetic, and Imaging Features. [PDF]

Eur J Neurol
Torchia E, Vandeputte P, Monforte M, Gillet C, Verny C, Bernard R, Tasca G, Spinazzi M.   +7 more
europepmc   +1 more source